Thomas W. McLean
Astellas Pharma (Japan)(JP)Astellas Pharma (China)(CN)Astellas Pharma (United Kingdom)(GB)Astellas Pharma (Netherlands)(NL)Astellas Pharma (United States)(US)Wake Forest University(US)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, Vascular Malformations and Hemangiomas, Acute Lymphoblastic Leukemia research, Renal and related cancers, Pediatric Pain Management Techniques
Most-Cited Works
- → Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations(2014)252 cited
- → Religiosity is Associated With the Use of Complementary Medical Therapies by Pediatric Oncology Patients(2003)102 cited
- Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.(1997)
- → Intensified therapy for infants with acute lymphoblastic leukemia(1997)95 cited
- → Central Venous Lines in Children With Lesser Risk Acute Lymphoblastic Leukemia: Optimal Type and Timing of Placement(2005)88 cited
- → Mutations in the transcriptional repressor REST predispose to Wilms tumor(2015)80 cited
- →